SARS-CoV-2 Sequencing and High-Throughput Detection
1 PM US/Canada Eastern Time, August 11, 2020
Attend Paragon Genomics Webinar to learn more! Click this link to register.
In this webinar, learn about the rapid, easy-to-use, ultra-high multiplex PCR-based Target enrichment solution for Next-Generation Sequencing (NGS), and how our proprietary CleanPlex background-removing technology can enable your lab to generate accurate and sensitive data, easily, quickly, and cost-effectively. This NGS panel is based on a highly sensitive amplicon sequencing technology and designed specifically for selectively amplifying and sequencing the full genome of SARS-CoV-2 virus. Also, hear about our collaboration with CHLA Center for Personalized Medicine in launching the full-genome SARS-CoV-2 sequencing research assays and establishing the CHLA COVID-19 Analysis Research Database (CARD).
At Paragon Genomics, we develop and commercialize rapid, easy-to-use, ultra-high multiplex PCR-based target enrichment solutions for Next-Generation Sequencing (NGS). Our proprietary CleanPlex® background-removing technology enables NGS customers to develop targeted sequencing assays that are accurate, sensitive, and simple, yet cost effective. Paragon Genomics responded quickly to the COVID-19 pandemic and developed amplicon-based targeted sequencing panels quickly for sequencing the full genome of the SARS-CoV-2 virus. We are committed to supporting the global efforts on COVID-19 coronavirus research and surveillance.